![Ahmed Daak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ahmed Daak
Corporate Officer/Principal at International Society for the Study of Fatty Acids & Lipids
Profile
Ahmed Daak currently works at International Society for the Study of Fatty Acids & Lipids, as Member.
Dr. Daak also formerly worked at the University of Khartoum, as Assistant Professor and Sancilio Pharmaceuticals Co., Inc., as VP-Medical Research & Clinical Development.
Dr. Daak received his undergraduate degree, graduate degree, and doctorate degree from the University of London.
Ahmed Daak active positions
Companies | Position | Start |
---|---|---|
International Society for the Study of Fatty Acids & Lipids | Corporate Officer/Principal | - |
Former positions of Ahmed Daak
Companies | Position | End |
---|---|---|
University of Khartoum | Corporate Officer/Principal | - |
Sancilio Pharmaceuticals Co., Inc.
![]() Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Chief Tech/Sci/R&D Officer | - |
Training of Ahmed Daak
University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Sancilio Pharmaceuticals Co., Inc.
![]() Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
International Society for the Study of Fatty Acids & Lipids |
- Stock Market
- Insiders
- Ahmed Daak